[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336707-105":59,"doc-detail-336707-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dab2-macrophages-support-fap-fibroblasts-in-shaping-tumor-barrier-and-inducing-poor-clinical-outcomes-in-liver-cancer","DAB2+ macrophages support FAP+ fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer","","Cancer-associated fibroblasts (CAFs) form a key immune barrier in liver cancer, yet their heterogeneity and cell-to-cell communication remain incompletely defined. Integrated single-cell, bulk, and spatial transcriptome analyses with multiplex immunofluorescence reveal expanded CAF populations, dominated by FAP+ fibroblasts. DAB2+ and SPP1+ tumor-associated macrophages reinforce FAP+ CAF functions via TGF-β, PDGF, and ADM signals, promoting immune barrier formation and worse survival. High FAP and DAB2 scores predict shorter survival and higher serum AFP, indicating potential relevance beyond liver cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dab2-macrophages-support-fap-fibroblasts-in-shaping-tumor-barrier-and-inducing-poor-clinical-outcomes-in-liver-cancer/336707/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dab2-macrophages-support-fap-fibroblasts-in-shaping-tumor-barrier-and-inducing-poor-clinical-outcomes-in-liver-cancer/336707.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main role of FAP+ fibroblasts in this study?","Question",{"text":112,"@type":113},"FAP+ fibroblasts are identified as the dominant CAF subtype and are mainly involved in extracellular matrix organization and angiogenesis within the tumor immune microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do DAB2+ macrophages influence FAP+ CAFs?",{"text":117,"@type":113},"DAB2+ (and SPP1+) tumor-associated macrophages reinforce FAP+ CAF functions through signaling pathways including TGF-β, PDGF, and ADM.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical outcomes are associated with DAB2+ TAMs and FAP+ CAFs?",{"text":121,"@type":113},"Their interaction promotes immune barrier formation and correlates with poorer patient survival and non-response to immunotherapy in hepatocellular carcinoma, with high FAP and DAB2 scores predicting shorter survival and higher serum AFP.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336707,1790186948,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Ivyspring  \nInternational Publisher  \nTheranostics  \n2024; 14(12): 4822-4843. doi: 10.7150/thno.99046  \nResearch Paper  \nDAB2+ macrophages support FAP+ fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer  \nFei Long1,2,\\#, Wei Zhong1,2,\\#, Faming Zhao2,\\#, Yaqi Xu1,2, Xin Hu1,2, Gaihua Jia1,2, Lanxiang Huang1,2, Kezhen Yi1,2, Na Wang1,2, Huaqi Si1,2, Jun Wang3, Bicheng Wang4, Yuan Rong2,􀀍, Yufeng Yuan5,􀀍, Chunhui Yuan3,􀀍, Fubing Wang1,2,6,􀀍  \n1. Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.  \n2. Center for Single-Cell Omics and Tumor Liquid Biopsy, Zhongnan Hospital of Wuhan University, Wuhan, China.  \n3. Department of Laboratory Medicine, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.  \n4. Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China  \n5. Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China  \n6. Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.  \n\\#These authors contributed equally to this work.  \n􀀍 Corresponding author: Fubing Wang, [wfb20042002@sina.com](wfb20042002@sina.com); Chunhui Yuan, [chunhuii.yuen@whu.edu.cn](chunhuii.yuen@whu.edu.cn); Yufeng Yuan, [yuanyf1971@whu.edu.cn](yuanyf1971@whu.edu.cn); Yuan Rong, [rongyuan323@whu.edu.cn](rongyuan323@whu.edu.cn).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2024.05.29; Accepted: 2024.07.31; Published: 2024.08.12  \nAbstract  \nBackground: Cancer-associated fibroblasts (CAFs) are the key components of the immune barrier in liver cancer. Therefore, gaining a deeper understanding of the heterogeneity and intercellular communication of CAFs holds utmost importance in boosting immunotherapy effectiveness and improving clinical outcomes.  \nMethods: A comprehensive analysis by combing single-cell, bulk, and spatial transcriptome profiling with multiplexed immunofluorescence was conducted to unravel the complexities of CAFs in liver cancer. Results: Through an integrated approach involving 235 liver cancer scRNA-seq samples encompassing over 1.2 million cells, we found that CAFs were particularly increased in hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). FAP+ fibroblasts were identified as the dominant subtype of CAFs, and which were mainly involved in extracellular matrix organization and angiogenesis. These CAFs were enriched in the tumor boundary of HCC, but diffusely scattered within ICC. The DAB2+ and SPP1+ tumor-associated macrophages (TAMs) reinforce the function of FAP+ CAFs through signals such as TGF-β, PDGF, and ADM. Notably, the interaction between DAB2+ TAMs and FAP+ CAFs promoted the formation of immune barrier and correlated with poorer patient survival, non-response to immunotherapy in HCC. High FAP and DAB2 immunohistochemical scores predicted shorter survival and higher serum AFP concentration in a local clinical cohort of 90 HCC patients. Furthermore, this communication pattern might be applicable to other solid malignancies as well.  \nConclusions: The interaction between DAB2+ TAMs and FAP+ CAFs appears crucial in shaping the immune barrier. Strategies aimed at disrupting this communication or inhibiting the functions of FAP+ CAFs could potentially enhance immunotherapy effectiveness and improve clinical outcomes.  \nKeywords: FAP+ fibroblast; DAB2+ macrophage; immune exclusion; single-cell RNA sequencing; prognosis  \nIntroduction  \nLiver cancer ranks as the third leading cause of cancer-related deaths and the sixth most prevalent  \ntumor t","cbCaisS1pdU7KL32","https://ap.wps.com/l/cbCaisS1pdU7KL32","pdf",14778698,22,"English","# Abstract\n# Introduction\n## Liver cancer burden and immunotherapy limitation\n## CAF heterogeneity and stromal remodeling\n## Markers and identification of CAF subtypes\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the main role of FAP+ fibroblasts in this study?\",\"answer\":\"FAP+ fibroblasts are identified as the dominant CAF subtype and are mainly involved in extracellular matrix organization and angiogenesis within the tumor immune microenvironment.\"},{\"question\":\"How do DAB2+ macrophages influence FAP+ CAFs?\",\"answer\":\"DAB2+ (and SPP1+) tumor-associated macrophages reinforce FAP+ CAF functions through signaling pathways including TGF-β, PDGF, and ADM.\"},{\"question\":\"What clinical outcomes are associated with DAB2+ TAMs and FAP+ CAFs?\",\"answer\":\"Their interaction promotes immune barrier formation and correlates with poorer patient survival and non-response to immunotherapy in hepatocellular carcinoma, with high FAP and DAB2 scores predicting shorter survival and higher serum AFP.\"}]","DAB2+ macrophages support FAP+ fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer | PDF",1790016307,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/798e948b355160dd16c30512377edb89.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01df72f0f5ed501012bb910a9121fa65.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/154b59adebc004eb89d096b86626bb2d.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54a8e5197b095775a4e9baad5836417a.webp",980,1268]